Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2010
06/02/2010CN101148680B Method for introducing plasmid vector containing gene cure segment in cell by nano particles
06/02/2010CN101116662B Application of sophocarpine in the preparation of medicine for treating adenovirus-caused inflammation
06/02/2010CN101099804B Traditional Chinese medicine composition for treating sars caused by epidemic poison retention lung and preparation method thereof
06/02/2010CN101002821B Ointment for treating herpes
06/02/2010CN101002786B Plaster for treating hepatitis B, and its preparing method
06/02/2010CA2646359A1 A carious-bacteria-kill nano-toothpaste
06/01/2010US7728127 Cross-linked glycopeptide-cephalosporin antibiotics
06/01/2010US7728121 Nucleotide sequences coding portion of viral early gene; generating immunoglobulin for detecting viral infection
06/01/2010US7728109 Antagonistic anti-hTNFSF13b human antibodies
06/01/2010US7728016 Substituted 5-membered ring compounds and their use
06/01/2010US7728014 Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity
06/01/2010US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/01/2010US7727712 Having an immunostimulatory sequence comprising the sequence 5'-C, G-3', wherein an HBV antigen is not administered in conjunction with administration of said nucleotide; for treatment of subject with hepatitis B virus
06/01/2010US7727529 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
06/01/2010US7727519 Method for treating hepatitis C virus with omega interferon
06/01/2010CA2512040C Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
06/01/2010CA2455595C Compositions of yeast cell walls and mannanoligosaccharides for control of coccidiosis
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2424501C New crystalline form of cefdinir
06/01/2010CA2415918C Agent for inhibiting adhesion of the pathogenic flora of the skin
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2384064C Vaccine against herpes simplex virus and human papilloma virus
06/01/2010CA2376025C Echinocandin derivatives, method for preparing same and application as antifungal agents
06/01/2010CA2358915C Modified hiv env polypeptides
06/01/2010CA2352231C Stable, attenuated rabies virus mutants and live vaccines thereof
06/01/2010CA2332627C Porcine circovirus and parvovirus vaccine
06/01/2010CA2309925C Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
06/01/2010CA2115839C Hla-restricted hepatitis b virus ctl epitopes
05/2010
05/28/2010CA2645455A1 A method of medically treating an individual
05/27/2010WO2010059531A2 Alpha-keto peracids and methods for producing and using the same
05/27/2010WO2010058550A1 Therapeutic or prophylactic agent for liver diseases comprising anti-human ggt antibody
05/27/2010WO2010058402A1 Novel anti-biofilm agents
05/27/2010WO2010057966A1 Use of cationic surfactants for the inactivation of toxins
05/27/2010WO2010057443A1 Use of 9,10-anthraquinone compounds
05/27/2010WO2010057418A1 A phenoxypyrimidine derivative, its preparation method and the use thereof
05/27/2010WO2010057330A1 Recombinant peptide molecule for treating saprolegniasis
05/27/2010WO2010057275A1 Cyclic peptides and uses thereof
05/27/2010WO2010025322A9 Magnetic nanodelivery of therapeutic agents across the blood brain barrier
05/27/2010WO2010017355A3 Small molecule inhibitors of retroviral assembly and maturation
05/27/2010WO2010013222A8 Pyrrole carboxylic acid derivatives as antibacterial agents
05/27/2010WO2010011347A3 Clip inhibitors and methods of modulating immune function
05/27/2010WO2009121848A3 Use of pseudomonas aeruginosa alkaline protease (apra) and inhibitors thereof in medicine and agriculture
05/27/2010WO2009001192A3 Novel compounds and their use
05/27/2010US20100132073 Sesquiterpenoid modifying enzymes
05/27/2010US20100130588 Novel lipid formulations for nucleic acid delivery
05/27/2010US20100130531 Pharmaceutical creams with reduced imiquimod impurities
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100130509 Novel antibiotics
05/27/2010US20100130508 Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole derivatives
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130503 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/27/2010US20100130496 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
05/27/2010US20100130491 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
05/27/2010US20100130470 Acrylamide derivatives as fab i inhibitors
05/27/2010US20100130451 Synthesis of tetracyclines and analogues thereof
05/27/2010US20100130450 Methods of Treating Fungal Infections
05/27/2010US20100130440 Antiviral nucleosides
05/27/2010US20100130437 Topical antibiotic composition for the prevention of lyme disease
05/27/2010US20100130430 Stabilized therapeutic small helical antiviral peptides
05/27/2010US20100130417 Transforming growth factor alpha hii
05/27/2010US20100130409 Cyclic peptide cxcr4 antagonists
05/27/2010US20100129901 Hepatitis c virus vaccine
05/27/2010US20100129864 Novel Bacteriocins, Transport and Vector System and Method of Use Thereof
05/27/2010US20100129462 Decolonizing agent for helicobacter pylori
05/27/2010US20100129439 Adjuvant Incorporation in Immunonanotherapeutics
05/27/2010US20100129438 Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA
05/27/2010US20100129437 Targeted intracellular delivery of antiviral agents
05/27/2010US20100129434 Compositions and methods for the treatment of mucormycosis and other fungal diseases
05/27/2010US20100129431 Idebenone composition for the treatment of neurological disorders
05/27/2010US20100129428 Supra molecular construct for delivery of interferon to a mammal
05/27/2010US20100129413 Method of treating and preventing viral infections
05/27/2010US20100129407 Tuberculosis Vaccine
05/27/2010US20100129405 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
05/27/2010US20100129403 Recombinant viral vaccine
05/27/2010US20100129401 Functional Influenza Virus Like Particles (VLPs)
05/27/2010US20100129400 Attenuated viruses, vaccines and methods of use thereof
05/27/2010US20100129399 Linear expression constructs for production of influenza virus particles
05/27/2010US20100129398 Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome
05/27/2010US20100129397 Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
05/27/2010US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same
05/27/2010US20100129387 Pharmaceutical composition containing the nmb0606 protein
05/27/2010US20100129334 Use of Lactobacillus casei for Increasing the Protection Provided by the Influenza Vaccine
05/27/2010US20100129321 Diaryl urea for treating virus infections
05/27/2010US20100129317 Azole nucleosides and use as inhibitors of rna and dna viral polymerases
05/27/2010US20100129314 Potent conjugates and hydrophilic linkers
05/27/2010US20100129297 Use of an aqueous grape seed extract combined with at least one fluorine salt to combat the formation or accumulation of dental biofilm and compositions comprising said combination
05/27/2010US20100129296 Extract of trigonella foenum-graecum
05/27/2010CA2781197A1 Hiv/siv vaccines for the generation of mucosal and systemic immunity
05/27/2010CA2743157A1 .alpha.-keto peracids and methods for producing and using the same
05/26/2010EP2189446A1 Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy]-n'-(butoxycarbonyl)benzamidine crystals
05/26/2010EP2189165A1 Capsular polysaccharide solubilisation and combination vaccines
05/26/2010EP2189161A1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
05/26/2010EP2189159A1 Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
05/26/2010EP2188281A1 Modulation of immune responses by administration of roxithromycin or its derivative
05/26/2010EP2188280A2 Imidazopyridinones
05/26/2010EP2188274A1 Viral polymerase inhibitors
05/26/2010EP2188265A1 Process for preparation of amorphous lopinavir
05/26/2010EP2188015A2 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
05/26/2010EP2187956A2 Use of a laminin peptide as a therapeutic agent
05/26/2010EP2187952A1 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents
1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 1798